JP Patent

JP4334344B2 — オキソピロリジン化合物、当該化合物の調製、並びにレベチラセタム及び類似体の製造におけるその化合物の使用

Assigned to ユセベ ファルマ ソシエテ アノニム · Expires 2009-09-30 · 17y expired

What this patent protects

Patent listed against Briviact.

Drugs covered by this patent

Patent Metadata

Patent number
JP4334344B2
Jurisdiction
JP
Classification
—
Expires
2009-09-30
Drug substance claim
No
Drug product claim
No
Assignee
ユセベ ファルマ ソシエテ アノニム
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.